APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

In-vitro Toxicity Testing

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global In-vitro Toxicity Testing Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

Report ID 174002300322 December 2025194 pages

Choose your research edition.

Industry ResearchIn-vitro Toxicity Testing Industry Research Report 2026120 pages · $2,950 USDIndustry Growth & TrendsGlobal In-vitro Toxicity Testing Industry Growth and Trends Forecast to 2032103 pages · $3,450 USDMarket StructureGlobal In-vitro Toxicity Testing Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032194 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal In-vitro Toxicity Testing Market Outlook and Growth Opportunities 2026199 pages · $4,250 USDMarket Analysis & ForecastGlobal In-vitro Toxicity Testing Market Analysis and Forecast 2026-2032191 pages · $4,950 USD

Market perspective

The global In-vitro Toxicity Testing market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The US & Canada market for In-vitro Toxicity Testing is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for In-vitro Toxicity Testing is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for In-vitro Toxicity Testing is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for In-vitro Toxicity Testing is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of In-vitro Toxicity Testing include Thermo Fisher Scientific Inc., Merck KGaA, Agilent Technologies Inc., General Electric Co., Evotec AG, Eurofins GSC Lux Sarl, Charles River Laboratories International Inc., CELTHER POLSKA Sp z o.o. and Bio-Rad Laboratories Inc., among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Includes

This report provides an overview of the global In-vitro Toxicity Testing market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of In-vitro Toxicity Testing and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents In-vitro Toxicity Testing revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the In-vitro Toxicity Testing market size, projected growth trends, production technologies, key applications, and end-use industries.

In-vitro Toxicity Testing Segment by Company

Thermo Fisher Scientific Inc.

Merck KGaA

Agilent Technologies Inc.

General Electric Co.

Evotec AG

Eurofins GSC Lux Sarl

Charles River Laboratories International Inc.

CELTHER POLSKA Sp z o.o.

Bio-Rad Laboratories Inc.

Abbott Laboratories

In-vitro Toxicity Testing Segment by Type

Static Well Plate System

Multi-compartmental Perfused Systems

In-vitro Toxicity Testing Segment by Application

Pharmaceutical and Biotechnology Companies

Academic and Research Institutions

Others

In-vitro Toxicity Testing Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global In-vitro Toxicity Testing market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of In-vitro Toxicity Testing and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of In-vitro Toxicity Testing.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of In-vitro Toxicity Testing in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global In-vitro Toxicity Testing industry.

Chapter 3: Detailed analysis of In-vitro Toxicity Testing companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, In-vitro Toxicity Testingrevenue, gross margin, and recent development, etc.

Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.

Chapter 8: Europe by type, by application and by country, revenue for each segment.

Chapter 9: China by type, and by application, revenue for each segment.

Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.

Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.

Chapter 12: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global In-vitro Toxicity Testing Market Size Growth Rate by Type (US$ Million): 2021 VS 2025 VS 2032 Table 2. Key Players of Static Well Plate System Table 3. Key Players of Multi-compartmental Perfused Systems Table 4. Global In-vitro Toxicity Testing Market Size Growth Rate by Application (US$ Million): 2021 VS 2025 VS 2032 Table 5. Key Players of Pharmaceutical and Biotechnology Companies Table 6. Key Players of Academic and Research Institutions Table 7. Key Players of Others Table 8. Global In-vitro Toxicity Testing Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 9. Global In-vitro Toxicity Testing Market Size by Region (2021-2026) & (US$ Million) Table 10. Global In-vitro Toxicity Testing Market Share by Region (2021-2026) Table 11. Global In-vitro Toxicity Testing Market Size by Region (2027-2032) & (US$ Million) Table 12. Global In-vitro Toxicity Testing Market Share by Region (2027-2032) Table 13. In-vitro Toxicity Testing Industry Trends Table 14. In-vitro Toxicity Testing Industry Drivers Table 15. In-vitro Toxicity Testing Industry Opportunities and Challenges Table 16. In-vitro Toxicity Testing Industry Restraints Table 17. Global In-vitro Toxicity Testing Revenue by Company (US$ Million) & (2021-2026) Table 18. Global In-vitro Toxicity Testing Revenue Market Share by Company (2021-2026) Table 19. Global In-vitro Toxicity Testing Players Revenue Ranking, 2024 VS 2025 VS 2026 Table 20. Global In-vitro Toxicity Testing Key Company Head Office and Area Served Table 21. Global In-vitro Toxicity Testing Company, Product Type & Application Table 22. Global In-vitro Toxicity Testing Company Establishment Date Table 23. Global Company Market Concentration Ratio (CR5 and HHI) Table 24. Global In-vitro Toxicity Testing by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 25. Global In-vitro Toxicity Testing Market Size by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global In-vitro Toxicity Testing Market Size by Type (2021-2026) & (US$ Million) Table 27. Global In-vitro Toxicity Testing Market Size by Type (2027-2032) & (US$ Million) Table 28. Global In-vitro Toxicity Testing Revenue Market Share by Type (2021-2026) Table 29. Global In-vitro Toxicity Testing Revenue Market Share by Type (2027-2032) Table 30. Global In-vitro Toxicity Testing Market Size by Application 2021 VS 2025 VS 2032 (US$ Million) Table 31. Global In-vitro Toxicity Testing Market Size by Application (2021-2026) & (US$ Million) Table 32. Global In-vitro Toxicity Testing Market Size by Application (2027-2032) & (US$ Million) Table 33. Global In-vitro Toxicity Testing Revenue Market Share by Application (2021-2026) Table 34. Global In-vitro Toxicity Testing Revenue Market Share by Application (2027-2032) Table 35. Thermo Fisher Scientific Inc. Company Information Table 36. Thermo Fisher Scientific Inc. Business Overview Table 37. Thermo Fisher Scientific Inc. In-vitro Toxicity Testing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 38. Thermo Fisher Scientific Inc. In-vitro Toxicity Testing Product Portfolio Table 39. Thermo Fisher Scientific Inc. Recent Development Table 40. Merck KGaA Company Information Table 41. Merck KGaA Business Overview Table 42. Merck KGaA In-vitro Toxicity Testing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 43. Merck KGaA In-vitro Toxicity Testing Product Portfolio Table 44. Merck KGaA Recent Development Table 45. Agilent Technologies Inc. Company Information Table 46. Agilent Technologies Inc. Business Overview Table 47. Agilent Technologies Inc. In-vitro Toxicity Testing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 48. Agilent Technologies Inc. In-vitro Toxicity Testing Product Portfolio Table 49. Agilent Technologies Inc. Recent Development Table 50. General Electric Co. Company Information Table 51. General Electric Co. Business Overview Table 52. General Electric Co. In-vitro Toxicity Testing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 53. General Electric Co. In-vitro Toxicity Testing Product Portfolio Table 54. General Electric Co. Recent Development Table 55. Evotec AG Company Information Table 56. Evotec AG Business Overview Table 57. Evotec AG In-vitro Toxicity Testing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 58. Evotec AG In-vitro Toxicity Testing Product Portfolio Table 59. Evotec AG Recent Development Table 60. Eurofins GSC Lux Sarl Company Information Table 61. Eurofins GSC Lux Sarl Business Overview Table 62. Eurofins GSC Lux Sarl In-vitro Toxicity Testing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 63. Eurofins GSC Lux Sarl In-vitro Toxicity Testing Product Portfolio Table 64. Eurofins GSC Lux Sarl Recent Development Table 65. Charles River Laboratories International Inc. Company Information Table 66. Charles River Laboratories International Inc. Business Overview Table 67. Charles River Laboratories International Inc. In-vitro Toxicity Testing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 68. Charles River Laboratories International Inc. In-vitro Toxicity Testing Product Portfolio Table 69. Charles River Laboratories International Inc. Recent Development Table 70. CELTHER POLSKA Sp z o.o. Company Information Table 71. CELTHER POLSKA Sp z o.o. Business Overview Table 72. CELTHER POLSKA Sp z o.o. In-vitro Toxicity Testing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 73. CELTHER POLSKA Sp z o.o. In-vitro Toxicity Testing Product Portfolio Table 74. CELTHER POLSKA Sp z o.o. Recent Development Table 75. Bio-Rad Laboratories Inc. Company Information Table 76. Bio-Rad Laboratories Inc. Business Overview Table 77. Bio-Rad Laboratories Inc. In-vitro Toxicity Testing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 78. Bio-Rad Laboratories Inc. In-vitro Toxicity Testing Product Portfolio Table 79. Bio-Rad Laboratories Inc. Recent Development Table 80. Abbott Laboratories Company Information Table 81. Abbott Laboratories Business Overview Table 82. Abbott Laboratories In-vitro Toxicity Testing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 83. Abbott Laboratories In-vitro Toxicity Testing Product Portfolio Table 84. Abbott Laboratories Recent Development Table 85. North America In-vitro Toxicity Testing Market Size by Type (2021-2026) & (US$ Million) Table 86. North America In-vitro Toxicity Testing Market Size by Type (2027-2032) & (US$ Million) Table 87. North America In-vitro Toxicity Testing Market Size by Application (2021-2026) & (US$ Million) Table 88. North America In-vitro Toxicity Testing Market Size by Application (2027-2032) & (US$ Million) Table 89. North America In-vitro Toxicity Testing Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 90. North America In-vitro Toxicity Testing Market Size by Country (2021-2026) Table 91. North America In-vitro Toxicity Testing Market Size by Country (2027-2032) Table 92. Europe In-vitro Toxicity Testing Market Size by Type (2021-2026) & (US$ Million) Table 93. Europe In-vitro Toxicity Testing Market Size by Type (2027-2032) & (US$ Million) Table 94. Europe In-vitro Toxicity Testing Market Size by Application (2021-2026) & (US$ Million) Table 95. Europe In-vitro Toxicity Testing Market Size by Application (2027-2032) & (US$ Million) Table 96. Europe In-vitro Toxicity Testing Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 97. Europe In-vitro Toxicity Testing Market Size by Country (2021-2026) Table 98. Europe In-vitro Toxicity Testing Market Size by Country (2027-2032) Table 99. China In-vitro Toxicity Testing Market Size by Type (2021-2026) & (US$ Million) Table 100. China In-vitro Toxicity Testing Market Size by Type (2027-2032) & (US$ Million) Table 101. China In-vitro Toxicity Testing Market Size by Application (2021-2026) & (US$ Million) Table 102. China In-vitro Toxicity Testing Market Size by Application (2027-2032) & (US$ Million) Table 103. Asia In-vitro Toxicity Testing Market Size by Type (2021-2026) & (US$ Million) Table 104. Asia In-vitro Toxicity Testing Market Size by Type (2027-2032) & (US$ Million) Table 105. Asia In-vitro Toxicity Testing Market Size by Application (2021-2026) & (US$ Million) Table 106. Asia In-vitro Toxicity Testing Market Size by Application (2027-2032) & (US$ Million) Table 107. Asia In-vitro Toxicity Testing Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 108. Asia In-vitro Toxicity Testing Market Size by Country (2021-2026) Table 109. Asia In-vitro Toxicity Testing Market Size by Country (2027-2032) Table 110. South America, Middle East & Africa In-vitro Toxicity Testing Market Size by Type (2021-2026) & (US$ Million) Table 111. South America, Middle East & Africa In-vitro Toxicity Testing Market Size by Type (2027-2032) & (US$ Million) Table 112. South America, Middle East & Africa In-vitro Toxicity Testing Market Size by Application (2021-2026) & (US$ Million) Table 113. South America, Middle East & Africa In-vitro Toxicity Testing Market Size by Application (2027-2032) & (US$ Million) Table 114. South America, Middle East & Africa In-vitro Toxicity Testing Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 115. South America, Middle East & Africa In-vitro Toxicity Testing Market Size by Country (2021-2026) Table 116. South America, Middle East & Africa In-vitro Toxicity Testing Market Size by Country (2027-2032) Table 117. Research Programs/Design for This Report Table 118. Authors List of This Report Table 119. Secondary Sources Table 120. Primary Sources List of Figures Figure 1. In-vitro Toxicity Testing Product Image Figure 2. Global In-vitro Toxicity Testing Market Size Growth Rate by Type, 2021 VS 2025 VS 2032 (US$ Million) Figure 3. Global In-vitro Toxicity Testing Market Share by Type: 2025 VS 2032 Figure 4. Static Well Plate System Image Figure 5. Multi-compartmental Perfused Systems Image Figure 6. Global In-vitro Toxicity Testing Market Size Growth Rate by Application, 2021 VS 2025 VS 2032 (US$ Million) Figure 7. Global In-vitro Toxicity Testing Market Share by Application: 2025 VS 2032 Figure 8. Pharmaceutical and Biotechnology Companies Image Figure 9. Academic and Research Institutions Image Figure 10. Others Image Figure 11. Global In-vitro Toxicity Testing Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 12. Global In-vitro Toxicity Testing Market Size (2021-2032) & (US$ Million) Figure 13. Global In-vitro Toxicity Testing Market Share by Region: 2025 VS 2032 Figure 14. Years Considered Figure 15. Global In-vitro Toxicity Testing Market Share by Players in 2025 Figure 16. Global Top 5 and 10 In-vitro Toxicity Testing Players Market Share by Revenue in 2025 Figure 17. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 18. Global In-vitro Toxicity Testing Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 19. Global In-vitro Toxicity Testing Revenue Market Share by Type (2021-2032) Figure 20. Global In-vitro Toxicity Testing Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 21. Global In-vitro Toxicity Testing Revenue Market Share by Application (2021-2032) Figure 22. North America In-vitro Toxicity Testing Market Size (2021-2032) & (US$ Million) Figure 23. North America In-vitro Toxicity Testing Market Share by Type (2021-2032) Figure 24. North America In-vitro Toxicity Testing Market Share by Application (2021-2032) Figure 25. North America In-vitro Toxicity Testing Market Share by Country (2021-2032) Figure 26. United States In-vitro Toxicity Testing Market Size (2021-2032) & (US$ Million) Figure 27. Canada In-vitro Toxicity Testing Market Size (2021-2032) & (US$ Million) Figure 28. Mexico In-vitro Toxicity Testing Market Size (2021-2032) & (US$ Million) Figure 29. Europe In-vitro Toxicity Testing Market Size (2021-2032) & (US$ Million) Figure 30. Europe In-vitro Toxicity Testing Market Share by Type (2021-2032) Figure 31. Europe In-vitro Toxicity Testing Market Share by Application (2021-2032) Figure 32. Europe In-vitro Toxicity Testing Market Share by Country (2021-2032) Figure 33. Germany In-vitro Toxicity Testing Market Size (2021-2032) & (US$ Million) Figure 34. France In-vitro Toxicity Testing Market Size (2021-2032) & (US$ Million) Figure 35. U.K. In-vitro Toxicity Testing Market Size (2021-2032) & (US$ Million) Figure 36. Italy In-vitro Toxicity Testing Market Size (2021-2032) & (US$ Million) Figure 37. Russia In-vitro Toxicity Testing Market Size (2021-2032) & (US$ Million) Figure 38. Nordic Countries In-vitro Toxicity Testing Market Size (2021-2032) & (US$ Million) Figure 39. China In-vitro Toxicity Testing Market Size (2021-2032) & (US$ Million) Figure 40. China In-vitro Toxicity Testing Market Share by Type (2021-2032) Figure 41. China In-vitro Toxicity Testing Market Share by Application (2021-2032) Figure 42. Asia In-vitro Toxicity Testing Market Size (2021-2032) & (US$ Million) Figure 43. Asia In-vitro Toxicity Testing Market Share by Type (2021-2032) Figure 44. Asia In-vitro Toxicity Testing Market Share by Application (2021-2032) Figure 45. Asia In-vitro Toxicity Testing Market Share by Country (2021-2032) Figure 46. Japan In-vitro Toxicity Testing Market Size (2021-2032) & (US$ Million) Figure 47. South Korea In-vitro Toxicity Testing Market Size (2021-2032) & (US$ Million) Figure 48. Taiwan In-vitro Toxicity Testing Market Size (2021-2032) & (US$ Million) Figure 49. Southeast Asia In-vitro Toxicity Testing Market Size (2021-2032) & (US$ Million) Figure 50. India In-vitro Toxicity Testing Market Size (2021-2032) & (US$ Million) Figure 51. Australia In-vitro Toxicity Testing Market Size (2021-2032) & (US$ Million) Figure 52. South America, Middle East & Africa In-vitro Toxicity Testing Market Size (2021-2032) & (US$ Million) Figure 53. South America, Middle East & Africa In-vitro Toxicity Testing Market Share by Type (2021-2032) Figure 54. South America, Middle East & Africa In-vitro Toxicity Testing Market Share by Application (2021-2032) Figure 55. South America, Middle East & Africa In-vitro Toxicity Testing Market Share by Country (2021-2032) Figure 56. Brazil In-vitro Toxicity Testing Market Size (2021-2032) & (US$ Million) Figure 57. South Africa In-vitro Toxicity Testing Market Size (2021-2032) & (US$ Million) Figure 58. Saudi Arabia In-vitro Toxicity Testing Market Size (2021-2032) & (US$ Million) Figure 59. Turkey In-vitro Toxicity Testing Market Size (2021-2032) & (US$ Million) Figure 60. Argentina In-vitro Toxicity Testing Market Size (2021-2032) & (US$ Million) Figure 61. UAE In-vitro Toxicity Testing Market Size (2021-2032) & (US$ Million) Figure 62. Egypt In-vitro Toxicity Testing Market Size (2021-2032) & (US$ Million) Figure 63. Chile In-vitro Toxicity Testing Market Size (2021-2032) & (US$ Million) Figure 64. Research Process Figure 65. Key Executives Interviewed

Scope & coverage.

Types
  • Static Well Plate System
  • Multi-compartmental Perfused Systems
Applications
  • Pharmaceutical and Biotechnology Companies
  • Academic and Research Institutions
  • Others
Companies covered
  • Thermo Fisher Scientific Inc.
  • Merck KGaA
  • Agilent Technologies Inc.
  • General Electric Co.
  • Evotec AG
  • Eurofins GSC Lux Sarl
  • Charles River Laboratories International Inc.
  • CELTHER POLSKA Sp z o.o.
  • Bio-Rad Laboratories Inc.
  • Abbott Laboratories

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Market Analysis by Type
  3. 1.2.1 Global In-vitro Toxicity Testing Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
  4. 1.2.2 Static Well Plate System
  5. 1.2.3 Multi-compartmental Perfused Systems
  6. 1.3 Market Analysis by Application
  7. 1.3.1 Global In-vitro Toxicity Testing Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
  8. 1.3.2 Pharmaceutical and Biotechnology Companies
  9. 1.3.3 Academic and Research Institutions
  10. 1.3.4 Others
  11. 1.4 Global Market Growth Prospects
  12. 1.5 Global In-vitro Toxicity Testing Growth Trends by Region
  13. 1.5.1 Global In-vitro Toxicity Testing Market Size by Region: 2021 VS 2025 VS 2032
  14. 1.5.2 In-vitro Toxicity Testing Market Size by Region (2021-2026)
  15. 1.5.3 In-vitro Toxicity Testing Market Size by Region (2027-2032)
  16. 1.6 Assumptions and Limitations
  17. 1.7 Study Goals and Objectives
  18. 1.8 Years Considered
2 Global In-vitro Toxicity Testing Market Dynamics
  1. 2.1 In-vitro Toxicity Testing Industry Trends
  2. 2.2 In-vitro Toxicity Testing Industry Drivers
  3. 2.3 In-vitro Toxicity Testing Industry Opportunities and Challenges
  4. 2.4 In-vitro Toxicity Testing Industry Restraints
3 Competitive Landscape by Company
  1. 3.1 Global In-vitro Toxicity Testing Revenue by Company (2021-2026)
  2. 3.2 Global In-vitro Toxicity Testing Players Revenue Ranking, 2024 VS 2025 VS 2026
  3. 3.3 Global In-vitro Toxicity Testing Key Company Head office and Area Served
  4. 3.4 Global In-vitro Toxicity Testing Company, Product Type & Application
  5. 3.5 Global In-vitro Toxicity Testing Company Establishment Date
  6. 3.6 Market Competitive Analysis
  7. 3.6.1 Global In-vitro Toxicity Testing Market CR5 and HHI
  8. 3.6.2 Global Top 5 and 10 In-vitro Toxicity Testing Players Market Share by Revenue in 2025
  9. 3.6.3 2025 In-vitro Toxicity Testing Tier 1, Tier 2, and Tier 3
4 In-vitro Toxicity Testing Market by Type
  1. 4.1 Global In-vitro Toxicity Testing Market Size by Type (2021 VS 2025 VS 2032)
  2. 4.2 Global In-vitro Toxicity Testing Market Size by Type (2021-2032)
  3. 4.3 Global In-vitro Toxicity Testing Market Size Share by Type (2021-2032)
5 In-vitro Toxicity Testing Market by Application
  1. 5.1 Global In-vitro Toxicity Testing Market Size by Application (2021 VS 2025 VS 2032)
  2. 5.2 Global In-vitro Toxicity Testing Market Size by Application (2021-2032)
  3. 5.3 Global In-vitro Toxicity Testing Market Size Share by Application (2021-2032)
6 Company Profiles
  1. 6.1 Thermo Fisher Scientific Inc.
  2. 6.1.1 Thermo Fisher Scientific Inc. Company Information
  3. 6.1.2 Thermo Fisher Scientific Inc. Business Overview
  4. 6.1.3 Thermo Fisher Scientific Inc. In-vitro Toxicity Testing Revenue and Gross Margin (US$ Million) & (2021-2026)
  5. 6.1.4 Thermo Fisher Scientific Inc. In-vitro Toxicity Testing Product Portfolio
  6. 6.1.5 Thermo Fisher Scientific Inc. Recent Developments
  7. 6.2 Merck KGaA
  8. 6.2.1 Merck KGaA Company Information
  9. 6.2.2 Merck KGaA Business Overview
  10. 6.2.3 Merck KGaA In-vitro Toxicity Testing Revenue and Gross Margin (US$ Million) & (2021-2026)
  11. 6.2.4 Merck KGaA In-vitro Toxicity Testing Product Portfolio
  12. 6.2.5 Merck KGaA Recent Developments
  13. 6.3 Agilent Technologies Inc.
  14. 6.3.1 Agilent Technologies Inc. Company Information
  15. 6.3.2 Agilent Technologies Inc. Business Overview
  16. 6.3.3 Agilent Technologies Inc. In-vitro Toxicity Testing Revenue and Gross Margin (US$ Million) & (2021-2026)
  17. 6.3.4 Agilent Technologies Inc. In-vitro Toxicity Testing Product Portfolio
  18. 6.3.5 Agilent Technologies Inc. Recent Developments
  19. 6.4 General Electric Co.
  20. 6.4.1 General Electric Co. Company Information
  21. 6.4.2 General Electric Co. Business Overview
  22. 6.4.3 General Electric Co. In-vitro Toxicity Testing Revenue and Gross Margin (US$ Million) & (2021-2026)
  23. 6.4.4 General Electric Co. In-vitro Toxicity Testing Product Portfolio
  24. 6.4.5 General Electric Co. Recent Developments
  25. 6.5 Evotec AG
  26. 6.5.1 Evotec AG Company Information
  27. 6.5.2 Evotec AG Business Overview
  28. 6.5.3 Evotec AG In-vitro Toxicity Testing Revenue and Gross Margin (US$ Million) & (2021-2026)
  29. 6.5.4 Evotec AG In-vitro Toxicity Testing Product Portfolio
  30. 6.5.5 Evotec AG Recent Developments
  31. 6.6 Eurofins GSC Lux Sarl
  32. 6.6.1 Eurofins GSC Lux Sarl Company Information
  33. 6.6.2 Eurofins GSC Lux Sarl Business Overview
  34. 6.6.3 Eurofins GSC Lux Sarl In-vitro Toxicity Testing Revenue and Gross Margin (US$ Million) & (2021-2026)
  35. 6.6.4 Eurofins GSC Lux Sarl In-vitro Toxicity Testing Product Portfolio
  36. 6.6.5 Eurofins GSC Lux Sarl Recent Developments
  37. 6.7 Charles River Laboratories International Inc.
  38. 6.7.1 Charles River Laboratories International Inc. Company Information
  39. 6.7.2 Charles River Laboratories International Inc. Business Overview
  40. 6.7.3 Charles River Laboratories International Inc. In-vitro Toxicity Testing Revenue and Gross Margin (US$ Million) & (2021-2026)
  41. 6.7.4 Charles River Laboratories International Inc. In-vitro Toxicity Testing Product Portfolio
  42. 6.7.5 Charles River Laboratories International Inc. Recent Developments
  43. 6.8 CELTHER POLSKA Sp z o.o.
  44. 6.8.1 CELTHER POLSKA Sp z o.o. Company Information
  45. 6.8.2 CELTHER POLSKA Sp z o.o. Business Overview
  46. 6.8.3 CELTHER POLSKA Sp z o.o. In-vitro Toxicity Testing Revenue and Gross Margin (US$ Million) & (2021-2026)
  47. 6.8.4 CELTHER POLSKA Sp z o.o. In-vitro Toxicity Testing Product Portfolio
  48. 6.8.5 CELTHER POLSKA Sp z o.o. Recent Developments
  49. 6.9 Bio-Rad Laboratories Inc.
  50. 6.9.1 Bio-Rad Laboratories Inc. Company Information
  51. 6.9.2 Bio-Rad Laboratories Inc. Business Overview
  52. 6.9.3 Bio-Rad Laboratories Inc. In-vitro Toxicity Testing Revenue and Gross Margin (US$ Million) & (2021-2026)
  53. 6.9.4 Bio-Rad Laboratories Inc. In-vitro Toxicity Testing Product Portfolio
  54. 6.9.5 Bio-Rad Laboratories Inc. Recent Developments
  55. 6.10 Abbott Laboratories
  56. 6.10.1 Abbott Laboratories Company Information
  57. 6.10.2 Abbott Laboratories Business Overview
  58. 6.10.3 Abbott Laboratories In-vitro Toxicity Testing Revenue and Gross Margin (US$ Million) & (2021-2026)
  59. 6.10.4 Abbott Laboratories In-vitro Toxicity Testing Product Portfolio
  60. 6.10.5 Abbott Laboratories Recent Developments
7 North America
  1. 7.1 North America In-vitro Toxicity Testing Market Size (2021-2032)
  2. 7.2 North America In-vitro Toxicity Testing Market Size by Type
  3. 7.2.1 North America In-vitro Toxicity Testing Market Size by Type (2021-2026)
  4. 7.2.2 North America In-vitro Toxicity Testing Market Size by Type (2027-2032)
  5. 7.2.3 North America In-vitro Toxicity Testing Market Share by Type (2021-2032)
  6. 7.3 North America In-vitro Toxicity Testing Market Size by Application
  7. 7.3.1 North America In-vitro Toxicity Testing Market Size by Application (2021-2026)
  8. 7.3.2 North America In-vitro Toxicity Testing Market Size by Application (2027-2032)
  9. 7.3.3 North America In-vitro Toxicity Testing Market Share by Application (2021-2032)
  10. 7.4 North America In-vitro Toxicity Testing Market Size by Country
  11. 7.4.1 North America In-vitro Toxicity Testing Market Size by Country (2021 VS 2025 VS 2032)
  12. 7.4.2 North America In-vitro Toxicity Testing Market Size by Country (2021-2026)
  13. 7.4.3 North America In-vitro Toxicity Testing Market Size by Country (2027-2032)
  14. 7.4.4 North America In-vitro Toxicity Testing Market Share by Country (2021-2032)
  15. 7.4.5 United States
  16. 7.4.6 Canada
  17. 7.4.7 Mexico
8 Europe
  1. 8.1 Europe In-vitro Toxicity Testing Market Size (2021-2032)
  2. 8.2 Europe In-vitro Toxicity Testing Market Size by Type
  3. 8.2.1 Europe In-vitro Toxicity Testing Market Size by Type (2021-2026)
  4. 8.2.2 Europe In-vitro Toxicity Testing Market Size by Type (2027-2032)
  5. 8.2.3 Europe In-vitro Toxicity Testing Market Share by Type (2021-2032)
  6. 8.3 Europe In-vitro Toxicity Testing Market Size by Application
  7. 8.3.1 Europe In-vitro Toxicity Testing Market Size by Application (2021-2026)
  8. 8.3.2 Europe In-vitro Toxicity Testing Market Size by Application (2027-2032)
  9. 8.3.3 Europe In-vitro Toxicity Testing Market Share by Application (2021-2032)
  10. 8.4 Europe In-vitro Toxicity Testing Market Size by Country
  11. 8.4.1 Europe In-vitro Toxicity Testing Market Size by Country (2021 VS 2025 VS 2032)
  12. 8.4.2 Europe In-vitro Toxicity Testing Market Size by Country (2021-2026)
  13. 8.4.3 Europe In-vitro Toxicity Testing Market Size by Country (2027-2032)
  14. 8.4.4 Europe In-vitro Toxicity Testing Market Share by Country (2021-2032)
  15. 8.4.5 Germany
  16. 8.4.6 France
  17. 8.4.7 U.K.
  18. 8.4.8 Italy
  19. 8.4.9 Russia
  20. 8.4.10 Nordic Countries
9 China
  1. 9.1 China In-vitro Toxicity Testing Market Size (2021-2032)
  2. 9.2 China In-vitro Toxicity Testing Market Size by Type
  3. 9.2.1 China In-vitro Toxicity Testing Market Size by Type (2021-2026)
  4. 9.2.2 China In-vitro Toxicity Testing Market Size by Type (2027-2032)
  5. 9.2.3 China In-vitro Toxicity Testing Market Share by Type (2021-2032)
  6. 9.3 China In-vitro Toxicity Testing Market Size by Application
  7. 9.3.1 China In-vitro Toxicity Testing Market Size by Application (2021-2026)
  8. 9.3.2 China In-vitro Toxicity Testing Market Size by Application (2027-2032)
  9. 9.3.3 China In-vitro Toxicity Testing Market Share by Application (2021-2032)
10 Asia (Excluding China)
  1. 10.1 Asia In-vitro Toxicity Testing Market Size (2021-2032)
  2. 10.2 Asia In-vitro Toxicity Testing Market Size by Type
  3. 10.2.1 Asia In-vitro Toxicity Testing Market Size by Type (2021-2026)
  4. 10.2.2 Asia In-vitro Toxicity Testing Market Size by Type (2027-2032)
  5. 10.2.3 Asia In-vitro Toxicity Testing Market Share by Type (2021-2032)
  6. 10.3 Asia In-vitro Toxicity Testing Market Size by Application
  7. 10.3.1 Asia In-vitro Toxicity Testing Market Size by Application (2021-2026)
  8. 10.3.2 Asia In-vitro Toxicity Testing Market Size by Application (2027-2032)
  9. 10.3.3 Asia In-vitro Toxicity Testing Market Share by Application (2021-2032)
  10. 10.4 Asia In-vitro Toxicity Testing Market Size by Country
  11. 10.4.1 Asia In-vitro Toxicity Testing Market Size by Country (2021 VS 2025 VS 2032)
  12. 10.4.2 Asia In-vitro Toxicity Testing Market Size by Country (2021-2026)
  13. 10.4.3 Asia In-vitro Toxicity Testing Market Size by Country (2027-2032)
  14. 10.4.4 Asia In-vitro Toxicity Testing Market Share by Country (2021-2032)
  15. 10.4.5 Japan
  16. 10.4.6 South Korea
  17. 10.4.7 Taiwan
  18. 10.4.8 Southeast Asia
  19. 10.4.9 India
  20. 10.4.10 Australia
11 South America, Middle East & Africa
  1. 11.1 South America, Middle East & Africa In-vitro Toxicity Testing Market Size (2021-2032)
  2. 11.2 South America, Middle East & Africa In-vitro Toxicity Testing Market Size by Type
  3. 11.2.1 South America, Middle East & Africa In-vitro Toxicity Testing Market Size by Type (2021-2026)
  4. 11.2.2 South America, Middle East & Africa In-vitro Toxicity Testing Market Size by Type (2027-2032)
  5. 11.2.3 South America, Middle East & Africa In-vitro Toxicity Testing Market Share by Type (2021-2032)
  6. 11.3 South America, Middle East & Africa In-vitro Toxicity Testing Market Size by Application
  7. 11.3.1 South America, Middle East & Africa In-vitro Toxicity Testing Market Size by Application (2021-2026)
  8. 11.3.2 South America, Middle East & Africa In-vitro Toxicity Testing Market Size by Application (2027-2032)
  9. 11.3.3 South America, Middle East & Africa In-vitro Toxicity Testing Market Share by Application (2021-2032)
  10. 11.4 South America, Middle East & Africa In-vitro Toxicity Testing Market Size by Country
  11. 11.4.1 South America, Middle East & Africa In-vitro Toxicity Testing Market Size by Country (2021 VS 2025 VS 2032)
  12. 11.4.2 South America, Middle East & Africa In-vitro Toxicity Testing Market Size by Country (2021-2026)
  13. 11.4.3 South America, Middle East & Africa In-vitro Toxicity Testing Market Size by Country (2027-2032)
  14. 11.4.4 South America, Middle East & Africa In-vitro Toxicity Testing Market Share by Country (2021-2032)
  15. 11.4.5 Brazil
  16. 11.4.6 South Africa
  17. 11.4.7 Saudi Arabia
  18. 11.4.8 Turkey
  19. 11.4.9 Argentina
  20. 11.4.9 UAE
  21. 11.4.9 Egypt
  22. 11.4.9 Chile
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources
    8. 13.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst